Literature DB >> 9566804

The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.

E E Yiannaki1, A G Tzioufas, M Bachmann, J Hantoumi, V Tsikaris, M Sakarellos-Daitsiotis, C Sakarellos, H M Moutsopoulos.   

Abstract

In a previous study it was shown that La/SSB contains four linear epitopes, p147-154, p291-302, p301-318 and p349-364. The aim of the present study was to investigate the value of the synthetic epitope analogues of the La/SSB autoantigen for the detection of antibodies to La/SSB, in comparison with recombinant La and fragments of this protein. A total of 122 sera with anti-La/SSB activity, from patients with primary Sjögren's syndrome (pSS) or systemic lupus erythematosus (SLE), were tested in various peptide-based assays. In addition, 62 sera from pSS or SLE patients with other autoantibody specificities and 95 sera from healthy individuals were used as controls. The autoantibody specificity was identified by counter immunoelectrophoresis and immunoblot. The peptide-based ELISA assays presented sensitivities ranging from 78% to 88-8% and specificities from 69% to 94-3%. Dot blot assays exhibited sensitivities ranging from 93-6% to 97%, but remarkably lower specificities from 56% to 88%. The most sensitive and specific peptide 349GSGKGKVQFQGKKTKF364 was synthesized and attached on a tetramer sequential oligopeptide carrier SOC4 and used for immunoassay development. Assays based on the recombinant native La protein, the La-C terminal (215 aa), and the N-terminal of La with a mutation at base pair 640 (nine adenines instead of eight) were also developed and compared with the SOC4 peptide-based assay. Of anti-La-positive sera, 88.1% were reactive with both the synthetic peptide SOC4-(349-364aa) and the recombinant La protein. Eighty-three percent of sera were reactive with the La N-terminus and 67.8% of sera were reactive with the La C-terminus. Using sera that were anti-Ro-positive but anti-La-negative, 37% were reactive with the recombinant protein, 26% with the La N-terminus, 33% with the La C-terminus and only 11 % with the synthetic peptide. Our results suggest that the synthetic peptide epitopes exhibit high sensitivity and specificity for the detection of anti-La/ SSB antibodies in ELISA and dot blot techniques. The peptide SOC4-(349-364aa) has the same sensitivity for the detection of anti-La/SSB antibodies as the recombinant protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566804      PMCID: PMC1904932          DOI: 10.1046/j.1365-2249.1998.00558.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  Intrinsic and extrinsic factors in protein antigenic structure.

Authors:  J A Berzofsky
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

4.  Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding.

Authors:  E K Chan; K F Sullivan; E M Tan
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

5.  Detection of anticentromere antibodies using cloned autoantigen CENP-B.

Authors:  N Rothfield; D Whitaker; B Bordwell; E Weiner; J L Senecal; W Earnshaw
Journal:  Arthritis Rheum       Date:  1987-12

6.  Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization.

Authors:  A G Tzioufas; E Yiannaki; M Sakarellos-Daitsiotis; J G Routsias; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1997-05       Impact factor: 4.330

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Serological profiles in subgroups of patients with Sjögren's syndrome.

Authors:  M N Manoussakis; A G Tzioufas; P J Pange; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

9.  Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.

Authors:  J B Harley; E L Alexander; W B Bias; O F Fox; T T Provost; M Reichlin; H Yamagata; F C Arnett
Journal:  Arthritis Rheum       Date:  1986-02

Review 10.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

View more
  16 in total

Review 1.  Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful.

Authors:  Tri Giang Phan; Richard C W Wong; Stephen Adelstein
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.

Authors:  A G Terzoglou; J G Routsias; S Avrameas; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.

Authors:  E Touloupi; J G Routsias; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen.

Authors:  E Yiannaki; P G Vlachoyiannopoulos; M N Manoussakis; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.

Authors:  E V Staikou; J G Routsias; A A Makri; A Terzoglou; M Sakarellos-Daitsiotis; C Sakarellos; G Panayotou; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.

Authors:  J D Goules; A V Goules; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

7.  T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.

Authors:  M G Papamattheou; J G Routsias; E E Karagouni; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas; E N Dotsika
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.

Authors:  A G Tzioufas; R Wassmuth; U G Dafni; A Guialis; H-J Haga; D A Isenberg; R Jonsson; J R Kalden; H Kiener; C Sakarellos; J S Smolen; N Sutcliffe; C Vitali; E Yiannaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

9.  Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay.

Authors:  Karl Egerer; Dirk Roggenbuck; Thomas Büttner; Barbara Lehmann; Annushka Kohn; Philipp von Landenberg; Rico Hiemann; Eugen Feist; Gerd-Rüdiger Burmester; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2011-07-21       Impact factor: 5.156

10.  Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.

Authors:  Claudia Arndt; Ralf Bergmann; Franziska Striese; Keresztély Merkel; Domokos Máthé; Liliana R Loureiro; Nicola Mitwasi; Alexandra Kegler; Frederick Fasslrinner; Karla Elizabeth González Soto; Christin Neuber; Nicole Berndt; Noemi Kovács; David Szöllősi; Nikolett Hegedűs; Gyula Tóth; Jan-Philipp Emmermann; Kuzhuvelil B Harikumar; Tibor Kovacs; Michael Bachmann; Anja Feldmann
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.